{"id":2386,"date":"2016-03-01T12:04:00","date_gmt":"2016-03-01T11:04:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2016\/haben-raas-hemmer-bei-hypertensiven-diabetikern-vorteile-gegenueber-anderen-antihypertensiva-in-der-praevention-von-gefaesskomplikationen"},"modified":"2016-03-01T12:04:00","modified_gmt":"2016-03-01T11:04:00","slug":"haben-raas-hemmer-bei-hypertensiven-diabetikern-vorteile-gegenueber-anderen-antihypertensiva-in-der-praevention-von-gefaesskomplikationen","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2016\/haben-raas-hemmer-bei-hypertensiven-diabetikern-vorteile-gegenueber-anderen-antihypertensiva-in-der-praevention-von-gefaesskomplikationen","title":{"rendered":"Haben RAAS-Hemmer bei hypertensiven Diabetikern Vorteile gegen\u00fcber anderen Antihypertensiva in der Pr\u00e4vention von Gef\u00e4\u00dfkomplikationen?"},"content":{"rendered":"<p>Hemmer des Renin-Angiotensin-Aldosteron-Systems (RAAS-H), d.h. ACE-Hemmer (ACE-H) und Angiotensin-II-Rezeptor-Blocker (AT-II-RB) gelten seit langem als Antihypertensiva der ersten Wahl bei hypertensiven Diabetikern, um kardiovaskul\u00e4re und renale Ereignisse zu vermindern. Die Evidenz f\u00fcr eine \u00dcberlegenheit der ACE-H gegen\u00fcber anderen Antihypertensiva war deutlicher als die der AT-II-RB. M\u00f6glicherweise ist dies darin begr\u00fcndet, dass die ACE-H zeitlich fr\u00fcher zur [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hemmer des Renin-Angiotensin-Aldosteron-Systems (RAAS-H), d.h. ACE-Hemmer (ACE-H) und Angiotensin-II-Rezeptor-Blocker (AT-II-RB) gelten seit langem als Antihypertensiva der ersten Wahl bei hypertensiven Diabetikern, um kardiovaskul\u00e4re und renale Ereignisse zu vermindern. Die Evidenz f\u00fcr eine \u00dcberlegenheit der ACE-H gegen\u00fcber anderen Antihypertensiva war deutlicher als die der AT-II-RB. M\u00f6glicherweise ist dies darin begr\u00fcndet, dass die ACE-H zeitlich fr\u00fcher zur [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[130,316,309,312,314,313,315,438,60,317,320,311,307,319,310,129,128,131,324,48,180,68,325,134,1060,306,56],"class_list":["post-2386","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-ace-hemmer","tag-angiotensin-ii-antagonisten","tag-angiotensin-ii-blocker","tag-angiotensin-ii-inhibitoren","tag-angiotensin-ii-rezeptor-antagonisten","tag-angiotensin-ii-rezeptor-blocker","tag-angiotensin-ii-rezeptor-inhibitoren","tag-antihypertensiva","tag-apoplektischer-insult","tag-at-ii-antagonisten","tag-at-ii-blocker","tag-at-ii-inhibitoren","tag-at-ii-rezeptor-antagonisten","tag-at-ii-rezeptor-blocker","tag-at-ii-rezeptor-inhibitoren","tag-beta-blocker","tag-betablocker","tag-betarezeptoren-blocker","tag-blutdruck","tag-diabetes-mellitus","tag-herzinsuffizienz","tag-hirninfarkt","tag-hypertonie","tag-kalziumantagonisten","tag-niereninsuffizienz","tag-sartane","tag-schlaganfall"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2386","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2386"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2386\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2386"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2386"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2386"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}